Material compatibility of human albumin
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 8
Abstract
Objective To investigate the compatibility of human albumin and its internal packaging materials of Sinopharm Lanzhou Biopharmaceutical Co., Ltd. Methods One batch of inner packaging materials (medium borosilicate glass-molded injection bottle and halogenated butyl rubber plug for injection) was extracted with 4 extraction solvents to conduct the toxicological evaluation of potential inner packaging extracts. Through the simulated acceleration test, the trend analysis of the elements in the sample and the inner surface of the glass bottle were observed, and the routine drug inspection items during the long-term stability test process were determined. Results The detection results of the leaching elements of the internal packaging materials did not exceed the limit of 50%, and the organic matter safety threshold (margin of safety, MOS) was greater than 1.0, indicating that both the leaching elements and the organic matter had no safety risk to the user under the current exposure. The results of the simulated acceleration test show that the drug will not have the risk of peeling tablets after the long-term stability condition was placed for a period of time, and the routine inspection items of the long-term stability test drugs all meet the requirements of the pharmacopoeia. Conclusion The inner packaging material has no significant impact on the quality of drugs and has good overall compatibility, making it suitable for packaging human albumin.
Authors and Affiliations
Yali WANG, Junhui WEI, Meichun YANG, Xiaojuan ZHOU, He REN, Sha LI, Nan XIE
Keywords
Related Articles
- EP ID EP738609
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.08.006
- Views 37
- Downloads 0
Effect of RhD antigen expression intensity on preparation of low positive quality control products for transfusion compatibility test
Objective To determine the reference red blood cells with weak agglutination intensity of low positive quality control products by comparing RhD antigen expression intensity difference according to the serological result...
Genetic background of RhD negative blood donors
Objective To analyze the genetic background of RhD-negative blood donors by detecting RHD and RHCE genes of those donors. Methods From March 2021 to May 2022, the blood samples of RhD-negative blood donors, who had been...
Selection of sterilizing-grade filter for preparation of human coagulation factor Ⅷ/ von Willebrand factor complex
Objective To screen the sterilizing-grade filters applicable for production of human coagulation factor Ⅷ/von Willebrand factor complex(FⅧ/VWF)and study the sterilization filtration process. Methods Four sterilizing-grad...
Clinical observations of the therapeutic effect of CLAG or FLAG bridging BuCy conditioning regimen in the treatment of childhood acute leukemia
Objective To determine the therapeutic efficacy of cladribine combined with BuCy conditioning regimen for childhood acute leukemia, and compare it with fludarabine. Methods The clinical data of 70 children with acute leu...
Correlation between serological screening of human T-lymphotropic virus antibodies and confirmatory tests
Objective To explore the correlation between serological screening of human T-lymphotropic virus antibodies (anti HTLV) and Western blot(WB) confirmatory tests among blood donors, so as to explore the infection status of...